✦ LIBER ✦

Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer a collaborative north central cancer treatment group/mayo clinic phase ii study

✍ Scribed by James E. Krook; Charles L. Loprinzi; Daniel J. Schaid; Carl G. Kardinal; James A. Mailliard; Delano M. Pfeifle; Neil M. Ellison; Nicholas F. Reuter; Robert A. Nelimark

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 397 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900201)65:3<418::aid-cncr2820650307>3.0.co;2-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II evaluation of menogaril in ci

A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the north central cancer treatment group and the mayo clinic

✍ Harry J. Long III; John A. Laurie; Harry S. Wieand; John H. Edmonson; Ralph Levi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB 👁 1 views

A phase III trial of 5-fluorouracil and

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study

✍ Michael J. O'Connell 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 1 views

The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment